Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126647431 | 12664743 | 1 | I | 201511 | 20160811 | 20160818 | 20160818 | EXP | FR-MEDAC PHARMA, INC.-1056485 | MEDAC | 44.00 | YR | F | Y | 0.00000 | 20160818 | OT | COUNTRY NOT SPECIFIED | FR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126647431 | 12664743 | 1 | PS | Metoject | METHOTREXATE SODIUM | 1 | Subcutaneous | N | 205776 | 1 | DF | SOLUTION FOR INJECTION | |||||||
126647431 | 12664743 | 2 | SS | PENTASA | MESALAMINE | 1 | Oral | N | 0 | 2 | DF | GRANULES | BID | ||||||
126647431 | 12664743 | 3 | SS | REMICADE | INFLIXIMAB | 1 | N | 0 | 100 | MG | POWDER FOR SOLUTION FOR INFUSION |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126647431 | 12664743 | 1 | Colitis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126647431 | 12664743 | LT |
126647431 | 12664743 | DS |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126647431 | 12664743 | Lung adenocarcinoma | |
126647431 | 12664743 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126647431 | 12664743 | 1 | 201501 | 201504 | 0 | |
126647431 | 12664743 | 3 | 20100322 | 20150107 | 0 |